TORONTO and PERTH, Western Australia, Aug. 26, 2026 (GLOBE NEWSWIRE) — Cygnus Metals Limited (ASX: CY5, TSXV: CYG, OTCQB: CYGGF) (Cygnus) announces that the unaudited interim results for the six months ended June 30, 2026 (H1 Interim Report) of Central Asia Metals PLC (CAML), together with the associated management’s discussion and analysis (collectively, the H1 Filings) have been released and made publicly available under Cygnus’ corporate profile on SEDAR+ at www.sedarplus.ca (SEDAR+). The H1 Interim Report will also be available on CAML’s website at https://www.centralasiametals.com/investors/reports-and-presentations/ and the London Stock Exchange website at https://www.londonstockexchange.com/stock/CAML/central-asia-metals-plc/company-page. This announcement is being disseminated in connection with the proposed transaction...

Engagement set to mark the first delivery of Majestic.ai as customer-operated licensed software, adding a software licensing model to Tiltan’s project-based services NEW YORK and NETANYA, Israel, Aug. 26, 2026 (GLOBE NEWSWIRE) — T3 Defense Inc. (Nasdaq: DFNS) (“T3 Defense” or the “Company”), today announced that its wholly owned subsidiary, Tiltan Software Engineering Ltd. (“Tiltan”), has been selected by a sensor systems developer and manufacturer to license Majestic.ai, Tiltan’s generative artificial intelligence (AI) synthetic data platform. This marks the first time Majestic.ai will be delivered as software the customer operates itself, rather than as a service Tiltan performs. Majestic.ai Majestic.ai is Tiltan’s AI platform for synthetic data generation. The physics-based platform produces labeled image and video datasets that...

Schiphol, August 26, 2026 – Aegon announces that it has filed with the U.S. Securities and Exchange Commission (SEC) today its registration statement on Form F-4 (Shareholder Circular) in connection with its upcoming Extraordinary General Meeting (EGM), expected to be held on October 8, 2026. The filing is an important step in Aegon’s planned redomiciliation to the United States and supports its ambition to become a leading US life insurance and retirement group.  The Shareholder Circular provides information on all items that will be proposed to the EGM relating to the redomiciliation. This includes the proposed future organizational and governance documents, which are in line with the previously announced governance framework and an Omnibus Incentive Plan. In addition, the Shareholder Circular includes a Voting Undertaking Agreement...

DENVER, Aug. 26, 2026 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings (NASDAQ: NTHI) has reached a point where the market conversation can move toward a much more consequential question: What happens if NEO100’s clinical results translate into a viable regulatory pathway for a difficult-to-treat form of brain cancer? On August 12, NeOnc reported positive topline Phase 2a results from its NEO100-01 study in patients with recurrent or progressive Grade III and Grade IV IDH1-mutant glioma. The study met its primary endpoint, with 48.9% six-month progression-free survival versus a pre-specified 20% benchmark, producing a reported p-value of 0.0047. NeOnc also reported median overall survival of 26.09 months, with 86.7% of patients alive at six months. Five of the 24 patients remained on treatment, including one partial response continuing...

Independent post-bid verification from ad-fraud researcher Dr. Augustine Fou provides third-party validation of IntentKey supply quality LITTLE ROCK, Ark., Aug. 26, 2026 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence advertising technology solutions, today announced the integration of FouAnalytics’ independent traffic quality measurement into IntentKey® audience modeling technology. FouAnalytics is an independent measurement firm founded by Dr. Augustine Fou, a widely recognized ad-fraud and traffic-quality researcher with three decades in digital marketing. Through post-bid verification, FouAnalytics measures which impressions reached genuine human audiences, providing Inuvo with an independent read on supply quality and third-party validation of IntentKey’s media decisioning. IntentKey...

Earnings Release: Tuesday, September 01, 2026, Before Market Opens  Conference Call and Webcast: Tuesday, September 01, 2026, at 08:30 A.M. Eastern Time ATHENS, Greece and NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) — Heidmar Maritime Holdings Corp. (the “Company” or “Heidmar”) (NASDAQ: HMR), today announces that it will release its results for the second quarter ended June 30, 2026, before market opens on Tuesday, September 01, 2026. Heidmar’s management team will host a conference call to discuss the Company’s financial results on Tuesday, September 01, 2026, at 08:30 a.m. Eastern Time (ET). Conference Call details: Participants should dial into the call 10 minutes before the scheduled time using the following numbers: +1 877 405 1226 (US Toll-Free Dial In) or +1 201 689 7823 (US and Standard International...

Daré’s proprietary formulation of topical sildenafil cream, 3.6% was well tolerated across all evaluated doses in the clinical study, with minimal systemic exposure Company continues activities necessary to advance its Sildenafil Cream toward the FDA’s 505(b)(2) regulatory pathway* while in parallel launching DARE to PLAY™ Sildenafil Cream, the 503B compounded version of its proprietary sildenafil cream formulation** DARE to PLAY Sildenafil Cream prescription dispensing and initial product revenue expected to commence in Q3 2026 SAN DIEGO, Aug. 26, 2026 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, today announced the publication of results from a clinical study of...